ImmunoScape

ImmunoScape (immunoscope.com): no confident changes recorded yet.

The homepage shows no content without JavaScript, so the latest live check could not read it. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

Exogene exogene.co.ukDirect competitorBoth use deep learning and TCR screening to discover TCR-based immunotherapies for solid tumors
TScan Therapeutics tscan.comPartial overlapBoth discover and develop TCR-based cell therapies for cancer including solid tumors
T-Therapeutics t-therapeutics.comPartial overlapBoth focus on next-generation TCR therapeutics for cancer indications
Immunai immunai.comPartial overlapBoth apply ML to immune profiling to support discovery of novel immunotherapy targets and candidates
ImmunoMind immunomind.comPartial overlapBoth offer AI-driven immunology platforms for designing personalized immune-targeting therapies

Cite this record

StartupHistory, “ImmunoScape” company record, https://startuphistory.org/c/immunoscope.com

Machine-readable: /c/immunoscope.com.json. How changes are found: method.